Dr. Sybil Hosek, protocol chair for HPTN 083-01 and HPTN 084-01, is a clinical adolescent psychologist at Stroger Hospital of Cook County and an assistant professor in the Division of Infectious Disease at Rush University in Chicago. Her research interests are focused on HIV prevention among adolescents and young adults.  

Dr. Sinead Delany-Moretlwe, HPTN 084 protocol chair, is a research professor and research director at Wits RHI at the University of the Witwatersrand, Johannesburg. A South African-born medical doctor, her research has focused on the intersections between sexual and reproductive health (SRH) and HIV, especially in adolescents. She has worked on several phase III trials of new HIV prevention technologies, including PrEP.  

Dr. Darrell Wheeler is president of the State University of New York at New Paltz. He currently serves on the U.S. Presidential Advisory Council on HIV/AIDS (PACHA); is a member of the SUNY Research Council; is on the HPTN Executive Management Committee; and co-chairs the HPTN Scholars Program. Wheeler earned his doctorate from the University of Pittsburgh, a master’s degree in public health, a master’s in social work from Howard University, and a bachelor’s degree in sociology from Cornell College. He served as vice chair of the U.S.

Nyaradzo Mavis Mgodi, (MBChB, MMed) is a clinical pathologist with over 10 years of experience conducting HIV clinical trials in women of reproductive age in sub-Saharan Africa, including Zimbabwe, the home of the University of Zimbabwe-Clinical Trials Research Centre, a DAIDS Clinical Trials Unit (CTU). As the lead investigator in Harare, she has overseen the implementation of several HPTN studies (HPTN 076, HPTN 082, HPTN 084) and the Microbicide Trials Network (MTN) studies assessing safety and effectiveness of oral PrEP and the dapivirine vaginal ring.